Family Pushes for Permanent Ban After Son’s Death From Retail Opioid

A Texas family is speaking out after their son, Sam, died following exposure to a concentrated 7‑Hydroxymitragynine (7‑OH) product he believed to be ordinary kratom. This tragedy highlights the growing concern among federal regulators, addiction experts, and public-health officials that these potent opioid compounds — often sold as "enhanced kratom" — may be fueling the next wave of the opioid epidemic.

Sam’s parents, Paul and Anne Marie, recount how their son never knew he was ingesting a powerful opioid. “He always called it kratom,” Paul explained, “He didn’t know what 7‑OH was. He didn’t know it was addictive. He didn’t know it could kill him.” They emphasize that Sam’s lack of awareness distinguishes this case from others.

Sam, born in Kingwood, Texas, in 1999, was a vibrant, artistic individual with a penchant for music, art, scuba diving, and nature. Growing up in Kingwood and Katy, he attended culinary school, earned a diploma in 2024, and showcased his talents as a bass guitarist and artist. He was known for his larger‑than‑life personality and a distinctive sense of humor, which endeared him to many.

The family only learned of Sam’s kratom and 7‑OH use after his death. They discovered remnants in his bedside drawer in March. Anne Marie noted that his behavior had drastically changed, prompting concern. He explained that he had purchased the 7‑OH from a vape shop, unaware that it was far stronger than the kratom he typically consumed. “He thought it was kratom,” Anne Marie said, adding that she herself visited the vape stores he frequented and confirmed the product’s potency.

Sam’s last words, recorded by his mother, revealed his confusion and despair: “I took three kratom teas. I told you I’d stopped, but I hadn’t.” Hospital records described him as experiencing “spiritual psychosis,” a condition characterized by religious or supernatural themes in psychotic symptoms. Sam’s parents emphasized that he had never struggled with addiction until his exposure to 7‑OH. He had even noted in his phone, “I’m addicted to this and I can’t stop.”

Scientific assessments emphasize that 7‑OH is a much more potent opioid than kratom’s primary compound, mitragynine. Scott Hemby, a professor at High Point University, described 7‑OH as fifteen times stronger and thirty times more potent, acting on the mu‑opioid receptor with significantly greater intensity. This potentiation underscores why the family’s story is emblematic of the risks posed by these concentrated opioid products.